Quinolone and Macrolide-Resistant Campylobacter jejuni in Pediatric Gastroenteritis Patients from Central Iran

Elnaz Abbasi1,2, Alex van Belkum3, Ehsanollah Ghaznavi-Rad1,4

  • 1Department of Microbiology & Immunology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.

Microbial Drug Resistance (Larchmont, N.Y.)
|April 26, 2019
PubMed

Insights

This study found genetically diverse, antibiotic-resistant Campylobacter jejuni causing pediatric diarrhea in Iran. High resistance to tetracycline, ciprofloxacin, and erythromycin was observed, necessitating careful antibiotic consideration for young children.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Campylobacter jejuni is a leading cause of bacterial gastroenteritis worldwide.
  • Antibiotic resistance in C. jejuni poses a significant threat to public health, particularly in pediatric populations.
  • Limited data exists on the prevalence and resistance patterns of C. jejuni in central Iran.

Purpose of the Study:

  • To determine the prevalence of C. jejuni in pediatric diarrhea cases in central Iran.
  • To characterize the antibiotic resistance patterns and identify associated resistance genes.
  • To investigate the genetic diversity of C. jejuni isolates.

Main Methods:

  • Stool specimens from 230 pediatric diarrhea patients were analyzed.
  • Identification of C. jejuni using modified Gram stain, culture media, and C. jejuni-specific PCR.
  • Antibiotic susceptibility testing, resistance gene detection (tet(o), cmeB, gyrA6, 23S rRNA mutation, qnrS), and Fla typing were performed.

Main Results:

  • C. jejuni was identified in 33% of cases by PCR.
  • High resistance rates were observed for tetracycline (82.2%), ciprofloxacin (71.1%), and erythromycin (68.8%).
  • Prevalence of resistance genes included tet(o) (97.3%), cmeB (96.8%), gyrA6 (68.7%), 23S rRNA mutation (64.5%), and qnrS (65.6%).
  • Fla typing revealed 11 distinct types, indicating genomic diversity.

Conclusions:

  • Genetically diverse, quinolone-macrolide-resistant C. jejuni is a significant cause of gastroenteritis in children in central Iran.
  • Pediatricians should consider these resistance patterns when prescribing antibiotics for pediatric diarrhea, especially in children under five.
  • Most C. jejuni diarrhea cases are self-limiting; antibiotics are reserved for severe complications.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
261
The Central Dogma01:25

The Central Dogma

Overview
139.2K
Measures of Central Tendency02:16

Measures of Central Tendency

The "center" of a data set is also a way of describing location. The two most widely used measures of the "center" of the data are the mean (average) and the median. The words "mean" and "average" are often used interchangeably. The substitution of one word for the other is common practice. The technical term is "arithmetic mean" and "average" is technically a center location. However, in practice among non-statisticians,...
20.2K